Kiniksa Pharmaceuticals
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed to modulate immunological signaling pathways for patients suffering from debilitating diseases with significant unmet medical need.

Year Established: 2015
Stock Ticker: KNSA
Exchange: NASDAQ